Form 8-K - Current report:
SEC Accession No. 0001193125-24-161223
Filing Date
2024-06-14
Accepted
2024-06-14 09:05:54
Documents
13
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d846753d8k.htm   iXBRL 8-K 29056
  Complete submission text file 0001193125-24-161223.txt   147134

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gh-20240612.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240612_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240612_pre.xml EX-101.PRE 10817
16 EXTRACTED XBRL INSTANCE DOCUMENT d846753d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 241043276
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)